Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Antimicrobial Prescribing Patterns in Patients with COVID-19 in Russian Multi-Field Hospitals in 2021: Results of the Global-PPS Project.
Avdeev S, Rachina S, Belkova Y, Kozlov R, Versporten A, Pauwels I, Goossens H, Bochanova E, Elokhina E, Portnjagina U, Reshetko O, Sychev I, Strelkova D, On Behalf Of Russian Global-Pps Project Study Group. Avdeev S, et al. Among authors: sychev i. Trop Med Infect Dis. 2022 May 16;7(5):75. doi: 10.3390/tropicalmed7050075. Trop Med Infect Dis. 2022. PMID: 35622702 Free PMC article.
Influence of ABCB1, CYP3A5 and CYP3A4 gene polymorphisms on prothrombin time and the residual equilibrium concentration of rivaroxaban in patients with non-valvular atrial fibrillation in real clinical practice.
Sychev DA, Sokolov AV, Reshetko OV, Fisenko VP, Sychev IN, Grishina EA, Bochkov PO, Shevchenko RV, Abdullaev SP, Denisenko NP, Ivashchenko DV, Sozaeva ZA, Kachanova AA. Sychev DA, et al. Among authors: sychev in. Pharmacogenet Genomics. 2022 Dec 1;32(9):301-307. doi: 10.1097/FPC.0000000000000483. Epub 2022 Oct 13. Pharmacogenet Genomics. 2022. PMID: 36256705
MicroRNAs as novel biomarkers for rivaroxaban therapeutic drug monitoring.
Rytkin E, Bure IV, Bochkov PO, Akmalova KA, Mirzaev KB, Cherniaeva MS, Ostroumova OD, Smirnov VV, Grishina EA, Saribekian AG, Sychev IN, Sychev DA. Rytkin E, et al. Drug Metab Pers Ther. 2021 Aug 13. doi: 10.1515/dmdi-2021-0118. Online ahead of print. Drug Metab Pers Ther. 2021. PMID: 34390638
MicroRNAs as novel biomarkers for rivaroxaban therapeutic drug monitoring.
Rytkin E, Bure IV, Bochkov PO, Akmalova KA, Mirzaev KB, Cherniaeva MS, Ostroumova OD, Smirnov VV, Grishina EA, Saribekian AG, Sychev IN, Sychev DA. Rytkin E, et al. Among authors: sychev in. Drug Metab Pers Ther. 2021 Aug 13;37(1):41-46. doi: 10.1515/dmpt-2021-0118. Drug Metab Pers Ther. 2021. PMID: 35385896
Genetic markers associated with adverse reactions of radioiodine therapy in thyroid cancer patients.
Denisenko NP, Kachanova AA, Sychev IV, Shuev GN, Perfilieva OM, Mukhamadiev RH, Kazakov RE, Milyutina OI, Konenkova OV, Ryzhkin SA, Zhmaeva EM, Kirienko SL, Ivashchenko DV, Bure IV, Ametov AS, Poddubnaya IV, Mirzaev KB, Sychev DA. Denisenko NP, et al. Among authors: sychev iv. Drug Metab Pers Ther. 2023 Jun 30;38(3):255-265. doi: 10.1515/dmpt-2023-0007. eCollection 2023 Sep 1. Drug Metab Pers Ther. 2023. PMID: 37708952
Genetic markers associated with adverse reactions of radioiodine therapy in thyroid cancer patients.
Denisenko NP, Kachanova AA, Sychev IV, Shuev GN, Perfilieva OM, Mukhamadiev RH, Kazakov RE, Milyutina OI, Konenkova OV, Ryzhkin SA, Zhmaeva EM, Kirienko SL, Ivashchenko DV, Bure IV, Ametov AS, Poddubnaya IV, Mirzaev KB, Sychev DA. Denisenko NP, et al. Among authors: sychev iv. Drug Metab Pers Ther. 2023 Jun 30. doi: 10.1515/dmdi-2023-0007. Online ahead of print. Drug Metab Pers Ther. 2023. PMID: 37381702
27 results